Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: Study of Stapokibatrt in Children Subjects With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Stapokibatrt in children with atopic dermatitis; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stapokibatrt

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Atopic Dermatitis | Phase 3 | Status: NOT_YET_RECRUITING